ARENA PHARMACEUTICALS INC
S-1/A, EX-27.1, 2000-07-19
PHARMACEUTICAL PREPARATIONS
Previous: ARENA PHARMACEUTICALS INC, S-1/A, EX-23.1, 2000-07-19
Next: ASTIR INC, 10SB12G/A, 2000-07-19



<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             MAR-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1999             MAR-31-2000
<CASH>                                       5,401,508              27,547,339
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                             5,573,560              27,706,265
<PP&E>                                       3,362,388               3,603,636
<DEPRECIATION>                               (589,006)               (754,969)
<TOTAL-ASSETS>                               8,525,840              30,700,932
<CURRENT-LIABILITIES>                        1,221,533                 899,649
<BONDS>                                              0                       0
                       18,251,949              38,797,410
                                          0                       0
<COMMON>                                           111                     159
<OTHER-SE>                                (13,899,549)            (16,394,510)
<TOTAL-LIABILITY-AND-EQUITY>                 8,525,840              30,700,932
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                            10,528,615               3,232,665
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             165,603                  59,579
<INCOME-PRETAX>                           (10,237,950)             (4,253,788)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                       (10,237,950)            (17,309,763)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                              (10,237,950)            (17,309,763)
<EPS-BASIC>                                  (10.05)                 (15.92)
<EPS-DILUTED>                                  (10.05)                 (15.92)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission